Format

Send to

Choose Destination
Br J Pharmacol. 2009 May;157(2):195-206. doi: 10.1111/j.1476-5381.2009.00057.x. Epub 2009 Mar 20.

Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics.

Author information

1
Centre de Recherches de Biochimie Macromoléculaire, UMR 5237, CNRS, UM-1, UM-2, CRBM-Department of Molecular Biophysics and Therapeutics, 1919 Route de Mende, Montpellier, France.

Abstract

The recent discovery of new potent therapeutic molecules that do not reach the clinic due to poor delivery and low bioavailability have made of delivery a key stone in therapeutic development. Several technologies have been designed to improve cellular uptake of therapeutic molecules, including cell-penetrating peptides (CPPs). CPPs were first discovered based on the potency of several proteins to enter cells. Numerous CPPs have been described so far, which can be grouped into two major classes, the first requiring chemical linkage with the drug for cellular internalization and the second involving formation of stable, non-covalent complexes with drugs. Nowadays, CPPs constitute very promising tools for non-invasive cellular import of cargo and have been successfully applied for in vitro and in vivo delivery of therapeutic molecules varying from small chemical molecule, nucleic acids, proteins, peptides, liposomes and particles. This review will focus on the structure/function and cellular uptake mechanism of CPPs in the general context of drug delivery. We will also highlight the application of peptide carriers for the delivery of therapeutic molecules and provide an update of their clinical evaluation.

PMID:
19309362
PMCID:
PMC2697800
DOI:
10.1111/j.1476-5381.2009.00057.x
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center